Royalty Pharma PLC at Goldman Sachs Global Healthcare Conference Transcript
Okay. Let's get underway. Apologies for the slight delay racing through the halls, knocking off not too many casualties. Welcome to the Tuesday afternoon session for the Goldman Sachs Healthcare Conference.
My name is Chris Shibutani. I'm one of the members of the research team cover pharmaceuticals and biotechnology, really, really pleased to have Royalty Pharma with us here today to participate in the conference.
The poor victim on the stage with me is Terry Coyne, Chief Financial Officer. I see that I think Marshall is here in hiding, George is hanging out too. So there are a lot of very smart folks, which actually brings me to some -- an introductory comment that I thought while we're seeing here amongst friends.
Terry, you and I actually go way back. I've always been a grumpy old fool. But I think you were basically a child back maybe 15 years ago working at JPMorgan when we were sort of under the same hood. And I asked this in the context of the fact that so many of the intelligence here at Royalty are former Wall Street Royalty themselves.
Talk about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |